BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

South Korean Firm Lunit Raises $150 Million in Capital Boost

Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, announced the successful completion ...

November 16, 2023 | News

AmoyDx and CST Expand Existing Partnership for the Development of Companion Diagnostics (CDx) to Support Precision Oncology

As the use of precision oncology therapeutics continues to advance in China, the partnership will provide AmoyDx with access to additional, highly validate...

November 15, 2023 | News

Ajinomoto Group Makes Strategic Move into Gene Therapy with $750 Million Acquisition of Forge Biologics, Bolstering Healthcare Portfolio for Exponential Growth

In the Medium-Term ASV Initiatives 2030 Roadmap, announced in February this year, Ajinomoto Co. identified four strategic growth areas including Healthcare...

November 15, 2023 | News

LGC acquires PolyDesign

PolyDesign manufacture and supply customers with their ‘PolyFrit’ products from their site in Redmond, Washington.   The proprietary frit t...

November 15, 2023 | News

In Conversation with Eugene Kang: Pioneering the Future of Cell Therapy with Thermo Fisher's CTS Detachable Dynabeads

In an exclusive Q&A by BioPharma APAC with Eugene Kang, Senior Product Manager for Cell Therapy at Thermo Fisher Scientific, we delve into the gr...

November 15, 2023 | News

Illumina Launches Global Health Access Initiative to Boost Pathogen Sequencing in Low- and Middle-Income Countries

Illumina Inc, a global leader in DNA sequencing and array-based technologies, announced the launch of the Global Health Access Initiative to su...

November 14, 2023 | News

SCG Cell Therapy's SCG101 Shows Promising Results in First-in-Human Trial for Advanced HBV-related Hepatocellular Carcinoma at AASLD Liver Meeting 2023

Results from a first-in-human clinical trial showed that SCG101 demonstrated promising antiviral and antitumor activities in patients with advanced HBV-rel...

November 14, 2023 | News

NSF TraQtion Powers Novozymes’ Raw Material Management in Industry First

NSF, a leading global public health and safety organization, is pleased to announce that Novozymes, a leader in biosolutions, has become the world&rs...

November 10, 2023 | News

Porton Advanced Partners with BioMap to Boost AAV Gene Therapy with AI Models

The goal is to harness the power of large-scale life science models, accelerating the design of AAV vectors, and expanding the application of AI models in ...

November 09, 2023 | News

BioRay Starts Phase I Study for BRY812, Targeted Antibody Drug Conjugate

LIV-1, also known as SLC39A6 or ZIP6, is a multipass transmembrane protein belonging to the ZIP superfamily of zinc transporters, possesses zinc trans...

November 08, 2023 | News

Biotheus Partners with BioNTech to Develop Bispecific Antibody Targeting PD-L1 and VEGF in Solid Tumors

BioNTech will hold exclusive licenses to develop and commercialize PM8002 globally excluding Greater China Biotheus Inc. ("Biotheus"),...

November 07, 2023 | News

Sanyou Bio Cheers KangaBio's IND Approval for Next-Gen IL-12 Prodrug Cancer Immunotherapy

These trials will primarily focus on late-stage solid tumors and the effectiveness will either be evaluated as a standalone therapy or in combination with ...

November 06, 2023 | News

Aquinnah Pharmaceuticals Advances Alzheimer's Tauopathy Program

Aquinnah Pharmaceuticals announced preclinical research findings for a novel therapeutic designed to slow or stop the progression of Alzheimer's disea...

October 31, 2023 | News

Merck Expands Oncology Pipeline with Hengrui Partnership for PARP1 Inhibitor and ADC

Collaboration to develop, manufacture and commercialize next-generation selective PARP1 inhibitor HRS-1167, with option to develop, manufacture and comme...

October 31, 2023 | News

Stay Connected